77 related articles for article (PubMed ID: 17805326)
1. Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
Roy JS; Van Themsche C; Demers M; Opdenakker G; Arnold B; St-Pierre Y
Leukemia; 2007 Dec; 21(12):2506-11. PubMed ID: 17805326
[TBL] [Abstract][Full Text] [Related]
2. EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth.
Bouchard F; Bélanger SD; Biron-Pain K; St-Pierre Y
Blood; 2010 Aug; 116(5):759-66. PubMed ID: 20472833
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Van Themsche C; Potworowski EF; St-Pierre Y
Biochem Biophys Res Commun; 2004 Mar; 315(4):884-91. PubMed ID: 14985095
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.
Moisan S; Demers M; Mercier J; Magnaldo T; Potworowski EF; St-Pierre Y
Leukemia; 2003 Apr; 17(4):751-9. PubMed ID: 12682633
[TBL] [Abstract][Full Text] [Related]
5. Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells.
Lalancette M; Aoudjit F; Potworowski EF; St-Pierre Y
Blood; 2000 Jan; 95(1):314-9. PubMed ID: 10607718
[TBL] [Abstract][Full Text] [Related]
6. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
Demers M; Magnaldo T; St-Pierre Y
Cancer Res; 2005 Jun; 65(12):5205-10. PubMed ID: 15958565
[TBL] [Abstract][Full Text] [Related]
7. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
[TBL] [Abstract][Full Text] [Related]
8. Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma.
Bélanger SD; St-Pierre Y
Blood; 2005 Jun; 105(12):4800-6. PubMed ID: 15705798
[TBL] [Abstract][Full Text] [Related]
9. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.
Masson V; de la Ballina LR; Munaut C; Wielockx B; Jost M; Maillard C; Blacher S; Bajou K; Itoh T; Itohara S; Werb Z; Libert C; Foidart JM; Noël A
FASEB J; 2005 Feb; 19(2):234-6. PubMed ID: 15550552
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Van Themsche C; Alain T; Kossakowska AE; Urbanski S; Potworowski EF; St-Pierre Y
J Immunol; 2004 Sep; 173(6):3605-11. PubMed ID: 15356104
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.
Rao S; Cai KQ; Stadanlick JE; Greenberg-Kushnir N; Solanki-Patel N; Lee SY; Fahl SP; Testa JR; Wiest DL
Cancer Res; 2016 Jun; 76(11):3387-96. PubMed ID: 27197189
[TBL] [Abstract][Full Text] [Related]
12. Quantitation, in vitro propagation, and characterization of preleukemic cells induced by radiation leukemia virus.
Yefenof E; Epszteyn S; Kotler M
Cancer Res; 1991 Apr; 51(8):2179-84. PubMed ID: 2009536
[TBL] [Abstract][Full Text] [Related]
13. Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.
Ishihara M; Nishida C; Tashiro Y; Gritli I; Rosenkvist J; Koizumi M; Okaji Y; Yamamoto R; Yagita H; Okumura K; Nishikori M; Wanaka K; Tsuda Y; Okada Y; Nakauchi H; Heissig B; Hattori K
Leukemia; 2012 Feb; 26(2):332-9. PubMed ID: 21931322
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
Zhang QL; Wang L; Zhang YW; Jiang XX; Yang F; Wu WL; Janin A; Chen Z; Shen ZX; Chen SJ; Zhao WL
Leukemia; 2009 Aug; 23(8):1507-14. PubMed ID: 19282831
[TBL] [Abstract][Full Text] [Related]
16. Single cell origin of radiation-induced thymic lymphoma in mice with cellular mosaicism.
Bessho M; Jinnai I; Hirashima K; Tanaka K; Tanooka H
Gan; 1984 Nov; 75(11):1002-5. PubMed ID: 6519394
[TBL] [Abstract][Full Text] [Related]
17. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
19. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
Hagenbeek TJ; Spits H
Leukemia; 2008 Mar; 22(3):608-19. PubMed ID: 18046443
[TBL] [Abstract][Full Text] [Related]
20. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
